A recent independent and randomized clinical study confirms that Bactiguard-coated Foley catheters reduce catheter associated urinary tract infections in ICU patients.
The study was conducted at the King Fahad Hospital in Saudi Arabia and included 60 patients in the Intensive Care Unit (ICU), who were catheterized for at least 3 days. The incidence of catheter associated urinary tract infections was 90 percent lower for patients with Bactiguard-coated Foley catheters (BIP Foley) compared to patients with standard silicone Foley catheters (10 cases vs. 1 case, P = 0.006). The study is published in Urology Annals*.
”This is the first randomized study focused solely on ICU patients and we are pleased that it confirms previously published results” says Dr Dorota Johansson, Clinical and Research Director at Bactiguard.
* The study is now available at the Urology Annals webpage(and will be soon available at PubMed):
http://www.urologyannals.com/searchresult.asp?search=noble+metal+alloy&journal=X&entries=10&pg=1&I1.x=0&I1.y=0&sa=,UrolAnn_2016_8_4_423_192099
For further information, please contact:
Dorota Johansson, Clinical and Research Director, mobile: +46 706 54 31 71
